This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,162.63, is a delivery order for the drug Trulicity 4.5 mg/0.5 ml pen, with a period of performance through December 4, 2023.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. As a leading pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying a wide array of medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies to federal government agencies, particularly within military and veterans' healthcare systems.